Respond Detect Report Investigate Adverse Events Following Immunization Dr S.M.Zahraei Center for Disease Control Ministry of Health and Medical Education.

Slides:



Advertisements
Similar presentations
The Vaccine Adverse Event Reporting System: A Tool for Safety and Surveillance Jane Woo, MD, MPH Vaccine Safety Branch Division of Epidemiology Office.
Advertisements

Module 6 Rotavirus vaccine AEFI monitoring
Importance of Vaccine Safety Decreases in disease risks and increased attention on vaccine risks Public confidence in vaccine safety is critical Low tolerance.
VACCINE SAFETY: 101 Pandemic Influenza Vaccine Safety Conference Atlanta, Georgia August 21, 2008.
IMMUNIZATION Immunization??? Reduce mortality and morbidity of mathernal and baby.
Core Tutorial in Pediatric Infectious Diseases for Third Year Medical Students Immunizations.
Travel Vaccination Dr. Samra A Yasin Petersfield Surgery 15 th September 2000.
Vaccination By; Dr.fatma alzahrani Jan Vaccination Objectives Definitions Type of immunization. Contraindication. Discussion of individual vaccines.
Pertussis and Pertussis Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Adverse Events Following Immunization (AEFI) Dr. Vikash Keshri.
Adverse Events Following Immunization, AEFI
Immunizations Donna Hills APN EdD Ball & Bindler.
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Pertussis and Pertussis Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
ELIZABETH WILLIAMS, MD FELLOW IN VACCINOLOGY AND VACCINE SAFETY VANDERBILT UNIVERSITY AUGUST 30 TH, 2012 Thimerosal and Vaccine Safety.
Vaccine Information Statement Hepatitis B (7/11/01) 42 U.S.C. § 300aa-26.
Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
Vaccine Safety Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention Revised.
Jeff Neccuzi, Director Division of Immunization Services WV Bureau for Public Health.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Immunisation Update. Changes to the immunisation schedule Contraindications and precautions to vaccination Epidemic update.
Immunization م. م زيد وحيد عاجل. Immunity : The ability to destroy a particular antigen, it is may be inherited (natural) or acquired (artificial). Natural.
Pediatric Immunization (EPI) Garcia, Garzon, Gaspar, Gatchalian, Gaw, Geraldoy, Geronimo, Geronimo, Geronimo.
Overview of AEFI Surveillance and Response Guidelines AEFI Strategic Communication Workshop Delhi, 9-10 August 2004 Dr. Adwoa Bentsi-Enchill, WHO/IVB.
WHO/V&B/AVI Adverse Events Following Immunization, AEFI A brief presentation on the adverse events following immunization, monitoring for AEFIs and taking.
Immunization By DR BAHA M HASSEN. 4month male baby with good health and normal development had in duration,painful and red swelling at site of previous.
Immune system dynamics. Figure 17.1 Antibody- antigen binding Figure 17.1 Antigens (Ag) Protein or polysaccharide Can be attached or free from cell Antibodies.
Medenilla, Judy; Medina, Kristianne; Medina, Sakura; Mejino, Carla; Melgarejo, Ivy; Mendoza, Alvin; Mendoza, Diana; Mendoza, Donne; Mendoza, Gracielle.
Global Training Network ProgrammeWorld Health Organization.
EPI VACCINES. BCG ( Bacille Calmette- Guerin)  Protects infants against TB  In powder form with diluents  Must be discarded after 6 hrs. or at the.
Adverse Events Following Immunization
Global Training Network ProgrammeWorld Health Organization.
IMMUNIZATIONS, PART I Janine Clark Adjo, M.D IMMUNIZATION SCHEDULE.
Global Training Network ProgrammeWorld Health Organization.
IMMUNIZATION.
INFECTIOUS COMPLICATIONS AFTER VACCINATION Dr Alireza Nateghian Associate professor of Pediatrics and Pediatric infectious diseases NATIONAL COMMITTEE.
Global Training Network ProgrammeWorld Health Organization A medical incident that takes place after an immunization, causes concern, and is believed to.
IMMUNITY IMMYNIZATION IMMUNITY. Active immunity are defenses developed by the body that last many years or even a life time. Active immunity are defenses.
BCG Vaccine Usual reactions induration: 2 – 4 wks pustule formation: 5 – 7 wks scar formation: 2 – 3 months Accelerated Reactions: induration: 2-3 days.
Expanded program of Immunization (EPI) Introduction The Expanded Program on Immunization (EPI) was established in 1974 depending on the success of the.
THE VACCINE CONTROVERSY Presented by: Joseph Goodfellow.
Expanded Program of Immunization (EPI). Definition It is program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Q Fever Dr Keat Teo (mbbs, Bmedsc, cs) Moora Health Centre
Immunization Safety Office Nuts and Bolts a Basic Course VACCINE SAFETY: nd National Immunization Conference Atlanta, Georgia March 17, 2008.
Module 3 IPV schedule, eligibility and contraindications Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 6 Monitoring Events Supposedly Attributable to Vaccination or Immunization (ESAVIs) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Polio and Polio Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
Risk Factors for Readmission Problem medicationsPrincipal diagnosisPoor health literacyPrior hospitalization Punk (depression)PolypharmacyPatient.
TM Influenza Vaccine Safety in Children: Data from VAERS John Iskander MD MPH Gina Mootrey DO MPH Penina Haber MPH Roseanne English-Bullard BS.
VACCINATIONS. Clarification and Definitions Vaccination: the administration of antigenic material to stimulate the immune system to develop adaptive immunity.
Vaccination د.رائد كريم العكيلي.
ADVRSE EVENTS FOLLOWING IMMUNIZATION
3. Key definitions Multi-partner training package on active TB drug safety monitoring and management (aDSM) July 2016.
VACCINES IMMUNISATION IN ADULTS
CD-JEV AEFI monitoring
Module 6 AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
JE vaccine eligibility
به نام خداوند هستي بخش.
تعريف AEFI هر پي آمد نامطلوب متعاقب ايمنسازي كه عقيده
Public Health Surveillance
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Smallpox Vaccine Contraindications and Screening
Module 6 Rotavirus vaccine AEFI monitoring
Presentation transcript:

Respond Detect Report Investigate Adverse Events Following Immunization Dr S.M.Zahraei Center for Disease Control Ministry of Health and Medical Education

AEFI is a medical incident that takes place after an immunization, causes concern, and is believed to be caused by immunization u Vaccine reaction è caused by vaccine’s inherent properties u Programme error è caused by error in vaccine preparation, handling or administration

u Coincidental è happens after immunization but not caused by it a chance association u Injection reaction è anxiety or pain of injection not vaccine u Unknown è cause can not be determined

Cluster of AEFI >=2 cases of the same adverse event following immunizations related in time, geography or in the vaccine administered –Why is it important to monitor for clustering?

Potential Objectives For AEFI Surveillance System Detect, correct, and prevent programme errors Identify problems with vaccine lots or brand Prevent false blame from coincidental events Maintain confidence by properly responding to parent/community concerns while increasing awareness (public and professional) about vaccine risks

Generate new hypotheses about vaccine reactions that are specific to the population Estimate rates of occurrence on AEFI in the local population, compared with trial and international data (particularly for new vaccines being introduced)

Programme Errors Non-sterile injection –infection Incorrect preparation –abscess (inadequate shaking) –drug effect (use of drug instead of vaccine/diluent)

Injection in wrong site –local reaction/abscess (wrong tissue level) –nerve damage Vaccine frozen –local reaction Contraindication ignored –avoidable severe reaction

Serious Events Anaphylactoid reaction (acute hypersensitivity reaction) Anaphylaxis Persistent (more than 3 hours) inconsolable screaming Hypotonic hyporesponsive episode Seizures, including febrile seizures (6-12 days for measles/MMR; 0-2 days for DTP) Encephalopathy (6-12 days for measles/MMR; 0-2 days for DTP)

Serious Events (cont…) Acute flaccid paralysis –(4-30 days for OPV recipient; 4-75 days for contact) Brachial neuritis –(2-28 days after tetanus containing vaccine) Thrombocytopaenia –(15-35 days after measles/MMR) Disseminated BCG infection Osteitis/osteomyelitis

THANK YOU FOR YOUR ATTENTION

DETECTING AND REPORTING AEFIs

Which Events To Report? Death, hospitalization, or other severe/unusual events Toxic shock syndrome Severe local reaction Sepsis Injection site abscess (bacterial/sterile) BCG lymphadenitis AEFIs causing concern or suspicion of vaccine involvement

Which Reports To Investigate? Investigate if possible programme error serious event of unexplained cause above expected rate (not just numbers) potential damage to the immunization programme Certain events (toxic shock syndrome, sepsis, abscess,and BCG lymphadenitis) are likely to arise from programme errors and must always be investigated

Contraindications True contraindications are rare Current serious febrile illness –delay vaccine administration History of severe AEFI after previous dose Evolving neurological disease –avoid whole cell pertussis vaccine –(e.g. uncontrolled epilepsy) Type 1 hypersensitivity to egg - avoid yellow fever & influenza but can use vaccines made in chick fibroblasts Symptomatic HIV –avoid BCG and yellow fever

Contraindications Anaphylactic reaction to neomicin, streptomycin or polymyxin B IPV Immunodeficiency, or immunodeficient household contact* OPV Encephalopathy within 7 days of administration DTP Anaphylactic reaction to vaccine or vaccine constituent Severe febrile illness All vaccines ContraindicationVaccine * Risk benefit assessment when administered to HIV positive individuals Adopted from Plotkin pg 66-67

Contraindications Anaphylactic reaction to common baker’s yeast Hepatitis B Anaphylactic reaction to egg, immunodeficiency Yellow fever NoneHib Anaphylaxis, pregnancy, immunodeficiency* MMR ContraindicationVaccine * Risk benefit assessment when administered to HIV-positive individuals Adopted from Plotkin pg 66-67